LAS VEGAS - Feb. 11, 2019 - TelAve -- TRICCAR Holdings, Inc., aka, TRICCAR, today announced Alden Townsend has joined TRICCAR's Scientific Advisory Board.

Alden Townsend began his career as a research geneticist with the USDA Agricultural Research Service in Ohio and later worked at the USDA's National Arboretum facility in Maryland. His responsibilities have included the improvement of urban plant species such as such as elm, red maple, spruce, alder, and hemlock. His work in developing a disease-resistant elm captured national attention. He started by making scores of controlled pollinations between European and Asiatic elms, germinating the seed, growing hybrid saplings, and inoculating them with the disease-causing fungus for the further testing of tolerance or resistance. A long-term process of cloning and screening followed.

Townsend has developed and released nine of the ten elm cultivars resistant to Dutch elm disease, and six red maple cultivars that are more adaptive to urban environments. He has also conducted extensive research on resistance of plants to insects, air pollutants, deicing salts, and drought. He has published more than 100 scientific and popular articles and provided leadership in various professional organizations including the International Society of Arboriculture, the Central States Forest Tree Improvement Council, the Metropolitan Tree Improvement Alliance, the Save the Elms Task Force, and Elm Watch.

More on TelAve News

• Join Artemis Women In Action Film Festival for an Incredible 4-Day Celebration of Female Action & Empowerment Heroes, Starting Thurs., April 25, 2019!
• Pro Wrestling Legends' Match to be Featured in Upcoming Movie
• Dry Bar Comedian Hits 1.5 Million Views in 1st Week
• Governor Gretchen Whitmer To Speak at Governor's Fitness Awards in Detroit
• Meals on Wheels of Central Maryland, Inc. will hold an event to raise awareness of the over 1 million meals served each year to the homebound in MD

Townsend holds a B. S. in Forest Science from Penn State University, an M.F. in genetics and ecology from Yale and a Ph.D. in forest genetics and plant breeding from Michigan State University. He is a member of Xi Sigma Pi (forestry honor society) and Gamma Sigma Delta (agricultural honor society), and has honored with awards for Arboricultural Research from the International Society of Arboriculture, the USDA Agricultural Research Service, the Jackson Dawson Memorial Medal from the Massachusetts Horticultural Society, an honor award from the Secretary of Agriculture, and the Luther Burbank Award from the American  Horticultural Society for "extraordinary achievements in plant breeding.

"Dr. Townsend's experience in plant genetics and breeding will play a vital role in the expansion of TRICCAR's plant-based research for bioceuticals and pharmaceuticals," said Katrina Yao, EVP and CFO. "As further commitment to our 'White Knight' strategy to provide the world's finest naturally-derived disease treatments, having Dr. Townsend's outstanding experience as part of our Scientific Advisory Board is another step in delivering low cost over-the-counter bioceuticals and FDA-approved drugs to hundreds of millions of consumers around the world."

More on TelAve News

• Donation by Televergence Solutions Sets in Motion Far-Reaching Ripple Effect Benefitting Women in Tech
• Karting Miami - First Indoor, Electric Go Kart Track in South Florida with Open-Wheeled Cars - Coming Soon to Dezerland Park
• Stonehurst Place named South's Number One Inn by Southern Living in magazine's 2019 South's Best Awards
• Headway Acquires New York Hospitality and National Event Staffing Business
• Performance Architects' Kirby Lunger and Astha Patni Win Top OATUG Awards at COLLABORATE 19 for Oracle Users Community Contributions

TRICCAR is a Las Vegas, Nevada-based bioceutical company creating treatments that support the health of those suffering from the world's most common diseases, including, obesity, cancer, pain, diabetic neuropathy, calcium deficiency, and trigeminal neuralgia. The Company competes in markets estimated at $1 trillion in annual sales for human and animal formulations.

For additional information on TRICCAR, please visit http://www.triccar.com.